Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 3560812, 15 pages
http://dx.doi.org/10.1155/2016/3560812
Review Article

Systematic Review on Chinese Herbal Medicine Induced Liver Injury

1The First Clinical Medical School, Beijing University of Chinese Medicine, Beijing, China
2Department of Gastroenterology and Hepatology, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, China
3Department of Infectious Disease, Beijing University of Chinese Medicine Affiliated Dongzhimen Hospital, Beijing, China

Received 10 June 2016; Revised 22 July 2016; Accepted 1 August 2016

Academic Editor: Victor Kuete

Copyright © 2016 Peng Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. L. Dossett, R. B. Davis, A. J. Lembo, and G. Y. Yeh, “Complementary and alternative medicine use by US adults with gastrointestinal conditions: results from the 2012 National Health Interview Survey,” The American Journal of Gastroenterology, vol. 109, no. 11, pp. 1705–1711, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. T.-G. Liu, S.-Q. Xiong, Y. Yan, H. Zhu, and C. Yi, “Use of Chinese herb medicine in cancer patients: a survey in southwestern China,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 769042, 5 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. H.-K. Shin, S.-J. Jeong, D. S. Huang, B.-K. Kang, and M. S. Lee, “Usage patterns and adverse experiences in traditional Korean medicine: results of a survey in South Korea,” BMC Complementary and Alternative Medicine, vol. 13, article 340, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Shumer, S. Warber, S. Motohara et al., “Complementary and alternative medicine use by visitors to rural Japanese family medicine clinics: results from the international complementary and alternative medicine survey,” BMC Complementary and Alternative Medicine, vol. 14, no. 1, article 360, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. Group of Hepatobiliary Disease of Digestive Disease Branch of Chinese Medical Association, “A multicenter survey on hospital inpatients with drug-induced acute liver injury in China,” Zhong Hua Xiao Hua Za Zhi, vol. 27, no. 7, pp. 437–440, 2007 (Chinese). View at Google Scholar
  6. Y. Zhou, L. Yang, Z. L. Liao, X. Y. He, Y. Y. Zhou, and H. Guo, “Epidemiology of drug-induced liver injury in China: a systematic analysis of the Chinese literature including 21 789 patients,” European Journal of Gastroenterology and Hepatology, vol. 25, no. 7, pp. 825–829, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Teschke, A. Wolff, C. Frenzel, J. Schulze, and A. Eickhoff, “Herbal hepatotoxicity: a tabular compilation of reported cases,” Liver International, vol. 32, no. 10, pp. 1543–1556, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Teschke, A. Wolff, C. Frenzel, and J. Schulze, “Review article: herbal hepatotoxicity—an update on traditional Chinese medicine preparations,” Alimentary Pharmacology and Therapeutics, vol. 40, no. 1, pp. 32–50, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Teschke, L. Zhang, H. Long et al., “Traditional Chinese Medicine and herbal hepatotoxicity: a tabular compilation of reported cases,” Annals of Hepatology, vol. 14, no. 1, pp. 7–19, 2015. View at Google Scholar · View at Scopus
  10. W.-J. Lee, H.-W. Kim, H.-Y. Lee, and C.-G. Son, “Systematic review on herb-induced liver injury in Korea,” Food and Chemical Toxicology, vol. 84, pp. 47–54, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Danan and R. Teschke, “RUCAM in drug and herb induced liver injury: the update,” International Journal of Molecular Sciences, vol. 17, no. 1, article 14, 2016. View at Publisher · View at Google Scholar
  12. J. P. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0, 2011, http://handbook.cochrane.org/.
  13. D. Moher, A. Liberati, J. Tetzlaff, D. G. Altman, and The PRISMA Group, “Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement,” International Journal of Surgery, vol. 8, no. 5, pp. 336–341, 2010. View at Publisher · View at Google Scholar
  14. Pharmacopoeia Commission of the Ministry of Health, Pharmacopoeia of The People's Republic of China, 1st Div, China Chemical Industry Press, Beijing, China, 2015 (Chinese).
  15. X. Li, C. Qu, Q. He et al., “Acute hepatitis induced by a Chinese herbal product Qibao Meiran Wan: a case study,” International Journal of Clinical and Experimental Medicine, vol. 8, no. 7, pp. 11624–11627, 2015. View at Google Scholar · View at Scopus
  16. E. Cortez, C. Boulger, and A. Bernard, “Ban Tu Wan hepatotoxicity,” BMJ Case Reports, vol. 2012, Article ID 006438, 4 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Dhanasekaran, V. Owens, and W. Sanchez, “Chinese skullcap in move free arthritis supplement causes drug induced liver injury and pulmonary infiltrates,” Case Reports in Hepatology, vol. 2013, Article ID 965092, 4 pages, 2013. View at Publisher · View at Google Scholar
  18. K. A. Jung, H. J. Min, S. S. Yoo et al., “Drug-induced liver injury: twenty five cases of acute hepatitis following ingestion of Polygonum multiflorum thunb,” Gut and Liver, vol. 5, no. 4, pp. 493–499, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Dong, D. Slain, J. Cheng, W. Ma, and W. Liang, “Eighteen cases of liver injury following ingestion of Polygonum multiflorum,” Complementary Therapies in Medicine, vol. 22, no. 1, pp. 70–74, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Viswanathan and A. Patel, “Hepatotoxicity associated with herbal tea containing kelp,” ACG Case Reports Journal, vol. 1, no. 1, pp. 55–57, 2013. View at Publisher · View at Google Scholar
  21. L. Yang, A. Aronsohn, J. Hart, and D. Jensen, “Herbal hepatoxicity from Chinese skullcap: a case report,” World Journal of Hepatology, vol. 4, no. 7, pp. 231–233, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. H. J. Kim, H. Kim, J. H. Ahn, and H. J. Suk, “Liver injury induced by herbal extracts containing mistletoe and kudzu,” Journal of Alternative and Complementary Medicine, vol. 21, no. 3, pp. 180–185, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Inoue, S. Yamazaki, M. Shimizu et al., “Liver injury induced by the Japanese herbal drug Kamishoyosan,” Gastroenterology and Hepatology, vol. 7, no. 10, pp. 692–695, 2011. View at Google Scholar · View at Scopus
  24. M. Wang, J. T. Qu, B. Dai, and C. L. Mei, “Fructus Xanthii poisoning: a case report and literature review,” Zhong Guo Quan Ke Yi Xue, vol. 16, no. 2, pp. 218–220, 2013 (Chinese). View at Google Scholar
  25. C. Yuan and L. Chen, “Two cases of recurrent jaundice induced by oral use of He-Shou-Wu,” Lin Chuang He Li Yong Yao, vol. 10, no. 7, article 78, 2014 (Chinese). View at Google Scholar
  26. A. H. Jiang and L. M. Yang, “One case of liver injury induced by Huang Yao Zi,” Zhong Guo Bao Jian Ying Yang, no. 5, article 3187, 2014 (Chinese). View at Google Scholar
  27. W. L. Zhang, J. W. Ma, and J. Dong, “Case analysis of liver injury induced by Sheng-He-Shou-Wu,” Kong Jun Yi Xue Za Zhi, vol. 2, no. 30, article 121, 2014 (Chinese). View at Google Scholar
  28. M. Yang, H. Y. Rao, and L. Wei, “Drug-induced liver injury: take care of herbal and dietary supplements,” Jian Kang Guan Li, vol. 12, pp. 57–60, 2014 (Chinese). View at Google Scholar
  29. X. F. Ren and J. M. Xu, “A clinical study on cases with traditional chinese medicine induced liver injury,” An Hui Yi Yao, vol. 19, no. 10, pp. 1997–2000, 2015 (Chinese). View at Google Scholar
  30. L. Mao, S. Q. Li, and Z. Q. Liang, “Drug-induced hepatitis due to oral traditional chinese medicine decoction,” Zhong Guo Yi Yao, vol. 1, no. 8, pp. 121–122, 2013 (Chinese). View at Google Scholar
  31. G. H. Wei, “Liver injury caused by traditional chinese medicine for psoriasis,” Jian Kang Bi Du ZaZhi, vol. 2, article 163, 2011 (Chinese). View at Google Scholar
  32. J. Ma, L. Zheng, Y.-S. He, and H.-J. Li, “Hepatotoxic assessment of Polygoni Multiflori Radix extract and toxicokinetic study of stilbene glucoside and anthraquinones in rats,” Journal of Ethnopharmacology, vol. 162, pp. 61–68, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. G. P. Lv, L. Z. Meng, D. Q. Han, H. Y. Li, J. Zhao, and S. P. Li, “Effect of sample preparation on components and liver toxicity of Polygonum multiflorum,” Journal of Pharmaceutical and Biomedical Analysis, vol. 109, pp. 105–111, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Wang, T. Han, L.-M. Xue et al., “Hepatotoxicity of kaurene glycosides from Xanthium strumarium L. fruits in mice,” Pharmazie, vol. 66, no. 6, pp. 445–449, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Wang, L. Ji, H. Liu, and Z. Wang, “Study of the hepatotoxicity induced by Dioscorea bulbifera L. rhizome in mice,” BioScience Trends, vol. 4, no. 2, pp. 79–85, 2010. View at Google Scholar · View at Scopus
  36. X.-X. Li, F.-Y. Du, H.-X. Liu, J.-B. Ji, and J. Xing, “Investigation of the active components in Tripterygium wilfordii leading to its acute hepatotoxicty and nephrotoxicity,” Journal of Ethnopharmacology, vol. 162, pp. 238–243, 2015. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Li, F. Shen, C. Guan et al., “Activation of Nrf2 protects against triptolide-induced hepatotoxicity,” PLoS ONE, vol. 9, no. 7, Article ID e100685, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. N. P. Chalasani, P. H. Hayashi, H. L. Bonkovsky, V. J. Navarro, W. M. Lee, and R. J. Fontana, “ACG clinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injury,” The American Journal of Gastroenterology, vol. 109, no. 7, pp. 950–966, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. W. M. Lee, R. H. Squires Jr., S. L. Nyberg, E. Doo, and J. H. Hoofnagle, “Acute liver failure: summary of a workshop,” Hepatology, vol. 47, no. 4, pp. 1401–1415, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Reuben, D. G. Koch, and W. M. Lee, “Drug-induced acute liver failure: results of a U.S. multicenter, prospective study,” Hepatology, vol. 52, no. 6, pp. 2065–2076, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. S. H. Bae, D. H. Kim, Y. S. Bae et al., “Toxic hepatitis associated with Polygoni multiflori,” The Korean Journal of Hepatology, vol. 16, no. 2, pp. 182–186, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. P. Ou, Y. Chen, B. Li et al., “Causes, clinical features and outcomes of drug-induced liver injury in hospitalized patients in a Chinese tertiary care hospital,” SpringerPlus, vol. 4, article 802, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. G. P. Lv, L. Z. Meng, D. Q. Han, H. Y. Li, J. Zhao, and S. P. Li, “Effect of sample preparation on components and liver toxicity of Polygonum multiflorum,” Journal of Pharmaceutical and Biomedical Analysis, vol. 109, pp. 105–111, 2015. View at Publisher · View at Google Scholar
  44. W. I. Cheung, M. L. Tse, T. Ngan et al., “Liver injury associated with the use of Fructus Psoraleae (Bol-gol-zhee or Bu-gu-zhi) and its related proprietary medicine,” Clinical Toxicology, vol. 47, no. 7, pp. 683–685, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Wang, Z. Song, H. Wang, Q. Li, Z. Cui, and Y. Zhang, “Angelica sinensis polysaccharide attenuates concanavalin A-induced liver injury in mice,” International Immunopharmacology, vol. 31, pp. 140–148, 2016. View at Publisher · View at Google Scholar · View at Scopus
  46. Y.-M. Liu, L.-L. Zhu, R. Li et al., “Xijiao Dihuang Decoction (犀角地黄) and Rehmannia glutinosa Libosch. protect mice against lipopolysaccharide and tumor necrosis factor alpha-induced acute liver failure,” Chinese Journal of Integrative Medicine, 2015. View at Publisher · View at Google Scholar
  47. S. Wu, Y. Yue, H. Tian et al., “Carthamus red from Carthamus tinctorius L. exerts antioxidant and hepatoprotective effect against CCl4-induced liver damage in rats via the Nrf2 pathway,” Journal of Ethnopharmacology, vol. 148, no. 2, pp. 570–578, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. B. Zhang, Q. Zhang, M. Liu et al., “Increased involvement of Panax notoginseng in the mechanism of decreased hepatotoxicity induced by Tripterygium wilfordii in rats,” Journal of Ethnopharmacology, vol. 185, pp. 243–254, 2016. View at Publisher · View at Google Scholar
  49. Livertox, “Chinese and Other Asian Herbal Medicines,” 2016, http://livertox.nih.gov/.
  50. Hepatox, http://www.hepatox.org/chPatentDrug.
  51. J. Rochon, P. Protiva, L. B. Seeff et al., “Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury,” Hepatology, vol. 48, no. 4, pp. 1175–1183, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. R. Teschke, C. Frenzel, J. Schulze, and A. Eickhoff, “Herbal hepatotoxicity: challenges and pitfalls of causality assessment methods,” World Journal of Gastroenterology, vol. 19, no. 19, pp. 2864–2882, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. R. Teschke, A. Wolff, C. Frenzel, A. Schwarzenboeck, J. Schulze, and A. Eickhoff, “Drug and herb induced liver injury: council for International Organizations of Medical Sciences scale for causality assessment,” World Journal of Hepatology, vol. 6, no. 1, pp. 17–32, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. R. Teschke, A. Eickhoff, and J. Schulze, “Drug- and herb-induced liver injury in clinical and translational hepatology: causality assessment methods, quo vadis?” Journal of Clinical and Translational Hepatology, vol. 1, no. 1, pp. 59–74, 2013. View at Publisher · View at Google Scholar
  55. T. Tran and W. M. Lee, “DILI: new insights into diagnosis and management,” Current Hepatitis Reports, vol. 12, no. 1, pp. 53–58, 2013. View at Publisher · View at Google Scholar · View at Scopus